Results 271 to 280 of about 51,125 (324)

Adjunctive anifrolumab for recalcitrant discoid lupus erythematosus in the setting of systemic lupus erythematosus: A case report. [PDF]

JAAD Case Rep
Soto-Canetti G, Talia J.
europepmc   +1 more source

Isotretinoin - Induced AGEP: A Case Report. [PDF]

Int Med Case Rep J
Alotaibi HM, AlNasser S, Aldossari A, Alluhaybi A, Alsergani R, Alrajban W.   +5 more
europepmc   +1 more source

Cutaneous vasculitis in systemic lupus erythematosus: epidemiology and risk factors over a 20-year follow-up. [PDF]

Rheumatology (Oxford)
Saleh A, Yee CS, Acquah A, Gordon C, Reynolds JA.   +4 more
europepmc   +1 more source

The nature of self-medication in Uganda: a systematic review and meta-analysis. [PDF]

BMC Public Health
Makeri D, Dilli PP, Pius T, Tijani NA, Opeyemi AA, Lawan KA, Jakheng SPE, Muhwezi R, Shabohurira A, Usman IM, Agwu E.   +10 more
europepmc   +1 more source

Emerging trends and new developments in global research on artemisinin and its derivatives. [PDF]

Heliyon
Lai Y, Zhang H, Chen X.
europepmc   +1 more source

Suboptimal Doses of Antimalarials Relative to Increasing Body Weight and the Risk of Plasmodium vivax Recurrence in the Republic of Korea Armed Forces, 2012-2021. [PDF]

J Korean Med Sci
Hwang YH, Yoon D, Go S, Yeom JS, Oh HS.
europepmc   +1 more source

Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis. [PDF]

Rheumatology (Oxford)
Etchegaray-Morales I, Mendoza-Pinto C, Munguía-Realpozo P, Solis-Poblano JC, Méndez-Martínez S, Ayón-Aguilar J, Abud-Mendoza C, García-Carrasco M, Cervera R.   +8 more
europepmc   +1 more source

Structure of Plasmodium vivaxN-myristoyltransferase with inhibitor IMP-1088: exploring an NMT inhibitor for antimalarial therapy. [PDF]

Acta Crystallogr F Struct Biol Commun
Mendez A, Bolling C, Taylor S, Makumire S, Staker B, Reers A, Hammerson B, Mayclin SJ, Abendroth J, Lorimer DD, Edwards TE, Tate EW, Subramanian S, Bell AS, Myler PJ, Asojo OA, Chakafana G.   +16 more
europepmc   +1 more source

Access, Utilization and Barriers to  Malaria Preventive Intervention  for Children under the Age of Five in Flood-Affected Region in South-South, Nigeria

David SC, Adebisi YA, Adebusuyi O, Omotayo FO.   +3 more
europepmc   +1 more source

Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials. [PDF]

Nat Commun
Naude M, van Heerden A, Reader J, van der Watt M, Niemand J, Joubert D, Siciliano G, Alano P, Njoroge M, Chibale K, Herreros E, Leroy D, Birkholtz LM.   +12 more
europepmc   +1 more source